P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid Tumors
Poseida Therapeutics, Inc.
Poseida Therapeutics, Inc.
SystImmune Inc.
Takeda
Novartis
Eastern Cooperative Oncology Group
Xencor, Inc.
Sun Yat-sen University
University of Wisconsin, Madison
Stanford University
University Health Network, Toronto
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)
National Cancer Institute (NCI)